125 related articles for article (PubMed ID: 932933)
1. GLC analysis of thioridazine, mesoridazine, and their metabolites.
Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma.
Dinovo EC; Gottschalk LA; Noble EP; Biener R
Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):489-96. PubMed ID: 4824823
[No Abstract] [Full Text] [Related]
3. Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine.
Chakraborty BS; Sardessai MS; Jaworski TJ; Midha KK; Hawes EM
Pharm Res; 1987 Jun; 4(3):207-13. PubMed ID: 3509283
[TBL] [Abstract][Full Text] [Related]
4. Absorption and excretion of thioridazine and mesoridazine in man.
Charalampous KD; Johnson PC; Estevez V
Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
[TBL] [Abstract][Full Text] [Related]
5. Identification of a metabolite of thioridazine and mesoridazine from human plasma.
Gruenke LD; Craig JC
Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):221-5. PubMed ID: 1162173
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat.
Lin G; Hawes EM; McKay G; Korchinski ED; Midha KK
Xenobiotica; 1993 Oct; 23(10):1059-74. PubMed ID: 8259689
[TBL] [Abstract][Full Text] [Related]
7. Phenolic metabolites of thioridazine in man.
Papadopoulos AS; Crammer JL; Cowan DA
Xenobiotica; 1985 Apr; 15(4):309-16. PubMed ID: 4024665
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
Shvartsburd A; Nwokeafor V; Smith RC
Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
[TBL] [Abstract][Full Text] [Related]
9. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
Niedzwiecki DM; Mailman RB; Cubeddu LX
J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914
[TBL] [Abstract][Full Text] [Related]
10. UVA-induced genetic effects of thioridazine, mesoridazine and sulforidazine: an in vitro study.
Schoonderwoerd SA; Beijersbergen van Henegouwen GM; Panday IR
Z Naturforsch C J Biosci; 1990 Jun; 45(6):638-44. PubMed ID: 2205215
[TBL] [Abstract][Full Text] [Related]
11. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
[TBL] [Abstract][Full Text] [Related]
12. Studies on thioridazine and mesoridazine metabolism. II. In vivo metabolism of tritiated drugs in rhesus monkeys.
Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
Commun Psychopharmacol; 1979; 3(5):323-7. PubMed ID: 121276
[No Abstract] [Full Text] [Related]
13. Studies on thioridazine and mesoridazine metabolism. I. Protein binding.
Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
Commun Psychopharmacol; 1979; 3(5):319-22. PubMed ID: 548210
[No Abstract] [Full Text] [Related]
14. A pilot of plasma thioridazine and metabolites in chronically treated patients.
Papadopoulos AS; Chand TG; Crammer JL; Lader S
Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
[TBL] [Abstract][Full Text] [Related]
15. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
Wells CE; Juenge EC; Furman WB
J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
[TBL] [Abstract][Full Text] [Related]
17. S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers.
Chakraborty BS; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Midha KK; Choc MG; Robinson WT
Drug Metabol Drug Interact; 1988; 6(3-4):425-37. PubMed ID: 3271648
[TBL] [Abstract][Full Text] [Related]
18. Sulphoxide metabolites of thioridazine in man.
Papadopoulos AS; Crammer JL
Xenobiotica; 1986 Dec; 16(12):1097-107. PubMed ID: 3798957
[TBL] [Abstract][Full Text] [Related]
19. Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.
Dorado P; Peñas-LLedó EM; de la Rubia A; LLerena A
Pharmacogenomics; 2009 Jul; 10(7):1083-9. PubMed ID: 19604081
[TBL] [Abstract][Full Text] [Related]
20. Albumin binding of thioridazine and some of its metabolites.
Vandeheeren FA; Belpaire FM
Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):86-91. PubMed ID: 1171660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
